Physician profile
David A Thompson
NPI 1336108521
$591.74
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $89.75 · 2021: $18.39 · 2022: $29.65 · 2023: $15.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $137.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.25 | 2019-2020 | |
| Abbvie INC. | $63.99 | 2021-2023 | Qulipta |
| Pfizer INC. | $49.55 | 2019 | |
| Amgen INC. | $42.14 | 2019-2020 | |
| Glaxosmithkline, LLC. | $29.47 | 2019 | |
| Merck Sharp & Dohme LLC | $27.18 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $25.78 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $23.25 | 2019 | |
| Vertiflex, INC. | $14.63 | 2019 | |
| Lilly USA, LLC | $13.97 | 2020 | |
| Amarin Pharma, INC. | $13.85 | 2019 | |
| Bausch Health US, LLC | $13.34 | 2020 | |
| Pacira Therapeutics, INC. | $13.20 | 2019 | |
| Shire North American Group INC | $12.92 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.